A Phase Ii, Open-Label, Extension Study of Long-Term Patisiran Treatment in Patients with Hereditary Transthyretin-Mediated (Hattr) Amyloidosis
AuthID
P-00S-ESG
P-00S-ESG
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service